Aberrant	O
activation	O
of	O
the	O
GIMAP	O
enhancer	O
by	O
oncogenic	O
transcription	O
factors	O
in	O
T	B-DISEASE
-	I-DISEASE
cell	I-DISEASE
acute	I-DISEASE
lymphoblastic	I-DISEASE
leukemia	E-DISEASE
.	O


The	O
transcription	O
factor	O
TAL1	O
/	O
SCL	O
is	O
one	O
of	O
the	O
most	O
prevalent	O
oncogenes	O
in	O
T	B-DISEASE
-	I-DISEASE
cell	I-DISEASE
acute	I-DISEASE
lymphoblastic	I-DISEASE
leukemia	E-DISEASE
(	O
T	B-DISEASE
-	I-DISEASE
ALL	E-DISEASE
)	O
,	O
a	O
malignant	O
disorder	O
resulting	O
from	O
leukemic	O
transformation	O
of	O
thymus	O
T	O
-	O
cell	O
precursors	O
.	O


TAL1	O
is	O
normally	O
expressed	O
in	O
hematopoietic	O
stem	O
cells	O
(	O
HSCs	O
)	O
but	O
is	O
silenced	O
in	O
immature	O
thymocytes	O
.	O


We	O
hypothesize	O
that	O
TAL1	O
contributes	O
to	O
leukemogenesis	O
by	O
activating	O
genes	O
that	O
are	O
normally	O
repressed	O
in	O
immature	O
thymocytes	O
.	O


Herein	O
,	O
we	O
identified	O
a	O
novel	O
TAL1	O
-	O
regulated	O
super	O
-	O
enhancer	O
controlling	O
the	O
GIMAP	O
locus	O
,	O
which	O
resides	O
within	O
an	O
insulated	O
chromosomal	O
locus	O
in	O
T	O
-	O
ALL	O
cells	O
.	O


The	O
GIMAP	O
genes	O
are	O
expressed	O
in	O
HSCs	O
and	O
mature	O
T	O
cells	O
but	O
are	O
downregulated	O
during	O
the	O
immature	O
stage	O
of	O
thymocyte	O
differentiation	O
.	O


The	O
GIMAP	O
enhancer	O
is	O
activated	O
by	O
TAL1	O
,	O
RUNX1	O
and	O
GATA3	O
in	O
human	O
T	O
-	O
ALL	O
cells	O
but	O
is	O
repressed	O
by	O
E	O
-	O
proteins	O
.	O


Overexpression	O
of	O
human	O
GIMAP	O
genes	O
in	O
immature	O
thymocytes	O
alone	O
does	O
not	O
induce	O
tumorigenesis	O
but	O
accelerates	O
leukemia	S-DISEASE
development	O
in	O
zebrafish	O
.	O


Our	O
results	O
demonstrate	O
that	O
aberrant	O
activation	O
of	O
the	O
GIMAP	O
enhancer	O
contributes	O
to	O
T	O
-	O
cell	O
leukemogenesis	O
.	O
